Regulatory Requirements for Bioequivalence

The bioequivalence for oral drug is determined by contrast the relative bioavailability of the logo drug compared to the generic drug. Food effect bioavailability are commonly conducted for new drugs and drug effect during the investigational new  drug (IND) phase to assess the effects of food on the rate and proportions of engrossment of a drug when the drug product is management shortly after a meal fed conditions, as compared to commanding under diet conditions

  • WHO Approaches
  • FDA Approach and regulations
  • TGA and risk management approach
  • Food-Effect Bioavailability and Fed Bioequivalence Studies
  • European Guidelines

Related Conference of Regulatory Requirements for Bioequivalence

August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
August 27-28, 2025

20th World Congress on Drug Formulation & Drug Delivery

Amsterdam, Netherlands
September 19-20, 2025

18th World Drug Delivery Summit

Paris, France
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 24-25, 2025

5th World Congress on Rare Diseases & Orphan Drugs

Aix-en-Provence, France
October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Aix-en-Provence, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, Aland Islands
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands

Regulatory Requirements for Bioequivalence Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in